Specifically, within upregulated, CAZA1, CO4A, ANXA4, and immunoglobulin kappa variable 3–20 (IGKV3-20) were significantly increased in mild disease COVID-19 while ACTN4 and fibrinogen beta (FGB) chain were significantly increased in severe COVID-19 individuals. This evidence concerns the gene ANXA4 and COVID-19.